Galmed Pharmaceuticals Ltd. financial data

Symbol
GLMD on Nasdaq
Location
C/O Meitar Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
6-K - Q2 2024 - Aug 28, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.05M shares -80%
Common Stock, Shares, Outstanding 6.36M shares
Common Stock, Value, Issued 263K USD +276%
Weighted Average Number of Shares Outstanding, Basic 6.29M shares +275%
Weighted Average Number of Shares Outstanding, Diluted 6.29M shares +275%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 534K USD -34%
General and Administrative Expense 688K USD -35.2%
Net Income (Loss) Attributable to Parent -1.12M USD +29.8%
Earnings Per Share, Basic 0.18 USD/shares -81.1%
Earnings Per Share, Diluted 0.18 USD/shares -81.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.84M USD +82.1%
Marketable Securities, Current 5.94M USD -21.4%
Assets, Current 10.1M USD +2.96%
Property, Plant and Equipment, Net 83K USD -27.2%
Operating Lease, Right-of-Use Asset 42K USD -81.2%
Assets 13.3M USD +0.48%
Accounts Payable, Current 1.2M USD -43.8%
Liabilities, Current 1.55M USD -42.9%
Operating Lease, Liability, Noncurrent 44K USD -80.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -435K USD +34.3%
Retained Earnings (Accumulated Deficit) -195M USD -3.11%
Stockholders' Equity Attributable to Parent 11.8M USD +11.7%
Liabilities and Equity 13.3M USD +0.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 20M shares
Common Stock, Shares, Issued 6.36M shares
Common Stock, Par or Stated Value Per Share 0.15 ILS/shares
Operating Lease, Liability 41K USD -81%
Property, Plant and Equipment, Gross 1.1M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 42K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD
Additional Paid in Capital 207M USD +3.34%